Comparison of Six Immunohistochemical Markers for the Histologic Diagnosis of Neoplasia in Barrett's Esophagus

Overview

Journal Virchows Arch

Specialties Cell Biology
Molecular Biology
Pathology

Date 2010 Sep 17

PMID 20844891

Citations 7

Authors

Andreas Weimann

Anja Rieger

Mathias Zimmermann

Monica Gross

Peter Hoffmann

Hortense Slevogt

Lars Morawietz

Affiliations

Soon will be listed here.

Abstract

In esophageal neoplasms, the histopathologic differentiation between Barrett's esophagus with or without intraepithelial neoplasia and adenocarcinoma is often challenging. Immunohistochemistry might help to differentiate between these lesions. The expression of CDX2, LI-cadherin, mucin 2 (MUC2), blood group 8 (BG8, Lewis(y)), claudin-2, and villin was investigated in normal gastroesophageal (n = 23) and in Barrett's (n = 17) mucosa, in low-grade (n = 12) and high-grade (n = 9) intraepithelial neoplasia (IEN) as well as in esophageal adenocarcinoma (n = 16), using immunohistochemistry. For CDX2 and LI-cadherin, the immunoreactivity score was highest in IEN while for MUC2, BG8, and villin, it dropped gradually from Barrett's via IEN to adenocarcinoma, and expression of Claudin-2 was only weak and focal in all lesions. The expression of MUC2 and LI-cadherin differed significantly between all examined lesions except between low-grade and high-grade IEN. MUC2 and LI-cadherin are useful immunohistochemical markers for the differentiation between normal glandular mucosa, Barrett's mucosa, IEN, and invasive carcinoma of the esophagus; however, none of the examined markers was helpful for the differentiation between low-grade and high-grade IEN.

Citing Articles

The Role of Mucin Expression in the Diagnosis of Oesophago-Gastric Cancer: A Systematic Literature Review.

Patel N, Geropoulos G, Patel P, Bhogal R, Harrington K, Singanayagam A Cancers (Basel). 2023; 15(21).

PMID: 37958425 PMC: 10650431. DOI: 10.3390/cancers15215252.

High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5.

Abu-Farsakh S, Wu T, Lalonde A, Sun J, Zhou Z BMC Gastroenterol. 2017; 17(1):33.

PMID: 28212604 PMC: 5316202. DOI: 10.1186/s12876-017-0590-0.

Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour.

Johnson A, Wright J, Zhao Z, Komaya T, Parikh A, Merchant N Histopathology. 2014; 66(2):225-33.

PMID: 25307987 PMC: 4302003. DOI: 10.1111/his.12535.

Possible roles of LI-Cadherin in the formation and maintenance of the intestinal epithelial barrier.

Baumgartner W Tissue Barriers. 2014; 1(1):e23815.

PMID: 24665380 PMC: 3879124. DOI: 10.4161/tisb.23815.

Liver-intestine-cadherin is a sensitive marker of intestinal differentiation during Barrett's carcinogenesis.

Mokrowiecka A, Zonnur S, Veits L, Musial J, Kordek R, Lochowski M Dig Dis Sci. 2012; 58(3):699-705.

PMID: 23053896 PMC: 3616226. DOI: 10.1007/s10620-012-2425-8.

References

Ko S, Chu K, Luk J, Wong B, Yuen S, Leung S . Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis. Biochem Biophys Res Commun. 2004; 319(2):562-8. DOI: 10.1016/j.bbrc.2004.04.197. View

Weimann A, Zimmermann M, Gross M, Slevogt H, Rieger A, Morawietz L . CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma. Int J Surg Pathol. 2010; 18(5):330-7. DOI: 10.1177/1066896910364228. View

Takeichi M . Morphogenetic roles of classic cadherins. Curr Opin Cell Biol. 1995; 7(5):619-27. DOI: 10.1016/0955-0674(95)80102-2. View

Fitzgerald R, Omary M, Triadafilopoulos G . Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus. J Cell Sci. 1997; 110 ( Pt 5):663-71. DOI: 10.1242/jcs.110.5.663. View

Eda A, Osawa H, Satoh K, Yanaka I, Kihira K, Ishino Y . Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol. 2003; 38(1):14-22. DOI: 10.1007/s005350300001. View

Kauer W, Peters J, DeMeester T, Ireland A, Bremner C, Hagen J . Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg. 1995; 222(4):525-31; discussion 531-3. PMC: 1234886. DOI: 10.1097/00000658-199522240-00010. View

Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B . Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology. 2001; 121(3):678-84. DOI: 10.1053/gast.2001.27124. View

Berndorff D, Gessner R, Kreft B, Schnoy N, Loch N, REUTTER W . Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine. J Cell Biol. 1994; 125(6):1353-69. PMC: 2290917. DOI: 10.1083/jcb.125.6.1353. View

Freund J, Domon-Dell C, Kedinger M, Duluc I . The Cdx-1 and Cdx-2 homeobox genes in the intestine. Biochem Cell Biol. 1999; 76(6):957-69. DOI: 10.1139/o99-001. View

10.

Riera J, Longmate J, Battifora H . The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval. Am J Surg Pathol. 1997; 21(12):1409-19. DOI: 10.1097/00000478-199712000-00003. View

11.

Phillips R, Frierson Jr H, Moskaluk C . Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol. 2003; 27(11):1442-7. DOI: 10.1097/00000478-200311000-00006. View

12.

Gyorffy H, Holczbauer A, Nagy P, Szabo Z, Kupcsulik P, Paska C . Claudin expression in Barrett's esophagus and adenocarcinoma. Virchows Arch. 2005; 447(6):961-8. DOI: 10.1007/s00428-005-0045-9. View

13.

Yamamoto H, Bai Y, Yuasa Y . Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem Biophys Res Commun. 2003; 300(4):813-8. DOI: 10.1016/s0006-291x(02)02935-2. View

14.

Grotzinger C, Kneifel J, Patschan D, Schnoy N, Anagnostopoulos I, Faiss S . LI-cadherin: a marker of gastric metaplasia and neoplasia. Gut. 2001; 49(1):73-81. PMC: 1728355. DOI: 10.1136/gut.49.1.73. View

15.

Haggitt R . Adenocarcinoma in Barrett's esophagus: a new epidemic?. Hum Pathol. 1992; 23(5):475-6. DOI: 10.1016/0046-8177(92)90121-i. View

16.

Goldblum J . Barrett's esophagus and Barrett's-related dysplasia. Mod Pathol. 2003; 16(4):316-24. DOI: 10.1097/01.MP.0000062996.66432.12. View

17.

Furuse M, Sasaki H, Tsukita S . Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol. 1999; 147(4):891-903. PMC: 2156154. DOI: 10.1083/jcb.147.4.891. View

18.

Hirohashi S . Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998; 153(2):333-9. PMC: 1852964. DOI: 10.1016/S0002-9440(10)65575-7. View

19.

Takeichi M . Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol. 1993; 5(5):806-11. DOI: 10.1016/0955-0674(93)90029-p. View

20.

Suh E, Traber P . An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol. 1996; 16(2):619-25. PMC: 231041. DOI: 10.1128/MCB.16.2.619. View